Pfizer provides heady cocktail of debt
Issuers crammed into the market on Tuesday with pharmaceutical firm Pfizer bringing the second multi-tranche Reverse Yankee this week, while Iberdrola ratcheted in pricing on a green bond — investors said they were enjoying the busy spell.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts